Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Nektar Therapeutics (NKTR)

-NasdaqGS
10.97 0.08(0.68%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 31,146   60,909   33,862   23,004  
Cost of Revenue8,960  12,877  5,011  11,661  
Gross Profit 22,186   48,032   28,851   11,343  
Operating Expenses
Research Development48,248  43,914  52,230  45,618  
Selling General and Administrative9,832  10,643  8,928  11,129  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (35,894) (6,525) (32,307) (45,404)
Income from Continuing Operations
Total Other Income/Expenses Net100  378  (95)741  
Earnings Before Interest And Taxes(35,794)(6,147)(32,402)(44,663)
Interest Expense10,230  10,203  10,141  10,188  
Income Before Tax(46,024)(16,350)(42,543)(54,851)
Income Tax Expense1,635  193  205  212  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(47,659)(16,543)(42,748)(55,063)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (47,659) (16,543) (42,748) (55,063)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (47,659) (16,543) (42,748) (55,063)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.